158 related articles for article (PubMed ID: 37790634)
1. Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice.
Qiu Y; Kang N; Wang X; Yao Y; Cui J; Zhang X; Zheng L
PeerJ; 2023; 11():e16155. PubMed ID: 37790634
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
[TBL] [Abstract][Full Text] [Related]
3. FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.
Wang XX; Wang D; Luo Y; Myakala K; Dobrinskikh E; Rosenberg AZ; Levi J; Kopp JB; Field A; Hill A; Lucia S; Qiu L; Jiang T; Peng Y; Orlicky D; Garcia G; Herman-Edelstein M; D'Agati V; Henriksen K; Adorini L; Pruzanski M; Xie C; Krausz KW; Gonzalez FJ; Ranjit S; Dvornikov A; Gratton E; Levi M
J Am Soc Nephrol; 2018 Jan; 29(1):118-137. PubMed ID: 29089371
[TBL] [Abstract][Full Text] [Related]
4. Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model.
Wang XX; Jiang T; Shen Y; Caldas Y; Miyazaki-Anzai S; Santamaria H; Urbanek C; Solis N; Scherzer P; Lewis L; Gonzalez FJ; Adorini L; Pruzanski M; Kopp JB; Verlander JW; Levi M
Diabetes; 2010 Nov; 59(11):2916-27. PubMed ID: 20699418
[TBL] [Abstract][Full Text] [Related]
5. Acetylshikonin from Zicao ameliorates renal dysfunction and fibrosis in diabetic mice by inhibiting TGF-β1/Smad pathway.
Li Z; Hong Z; Peng Z; Zhao Y; Shao R
Hum Cell; 2018 Jul; 31(3):199-209. PubMed ID: 29549584
[TBL] [Abstract][Full Text] [Related]
6. Effect of chenodeoxycholic acid on fibrosis, inflammation and oxidative stress in kidney in high-fructose-fed Wistar rats.
Hu Z; Ren L; Wang C; Liu B; Song G
Kidney Blood Press Res; 2012; 36(1):85-97. PubMed ID: 22948014
[TBL] [Abstract][Full Text] [Related]
7. AANG Prevents Smad3-dependent Diabetic Nephropathy by Restoring Pancreatic β-Cell Development in db/db Mice.
Chung JY; Tang PM; Chan MK; Wang L; Huang XR; To KF; Ma RC; Lan HY
Int J Biol Sci; 2022; 18(14):5489-5502. PubMed ID: 36147472
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
9. Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice.
Wu H; Liu G; He Y; Da J; Xie B
Eur J Pharmacol; 2019 Sep; 858():172393. PubMed ID: 31085240
[TBL] [Abstract][Full Text] [Related]
10. Farnesoid X receptor activation protects against renal fibrosis via modulation of β-catenin signaling.
Sun DQ; Yuan F; Fu MZ; Zhong MY; Zhang SL; Lu Y; Targher G; Byrne CD; Zheng MH; Yuan WJ
Mol Metab; 2024 Jan; 79():101841. PubMed ID: 38036169
[TBL] [Abstract][Full Text] [Related]
11. Knockout of farnesoid X receptor gene aggravates cisplatin-induced kidney injury.
Zhang L; Li A; Huang Z; Wang Y; Yi B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):174-182. PubMed ID: 35545407
[TBL] [Abstract][Full Text] [Related]
12. Chrysin Inhibits Advanced Glycation End Products-Induced Kidney Fibrosis in Renal Mesangial Cells and Diabetic Kidneys.
Lee EJ; Kang MK; Kim DY; Kim YH; Oh H; Kang YH
Nutrients; 2018 Jul; 10(7):. PubMed ID: 29987200
[TBL] [Abstract][Full Text] [Related]
13. Melatonin Ameliorates Renal Fibrosis Through the Inhibition of NF-κB and TGF-β1/Smad3 Pathways in db/db Diabetic Mice.
Fan Z; Qi X; Yang W; Xia L; Wu Y
Arch Med Res; 2020 Aug; 51(6):524-534. PubMed ID: 32473749
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner.
Bae EH; Choi HS; Joo SY; Kim IJ; Kim CS; Choi JS; Ma SK; Lee J; Kim SW
PLoS One; 2014; 9(1):e86553. PubMed ID: 24475141
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
16. Effect of TET2 on the pathogenesis of diabetic nephropathy through activation of transforming growth factor β1 expression via DNA demethylation.
Yang L; Zhang Q; Wu Q; Wei Y; Yu J; Mu J; Zhang J; Zeng W; Feng B
Life Sci; 2018 Aug; 207():127-137. PubMed ID: 29705354
[TBL] [Abstract][Full Text] [Related]
17. Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy.
Tang F; Hao Y; Zhang X; Qin J
Drug Des Devel Ther; 2017; 11():2813-2826. PubMed ID: 29033543
[TBL] [Abstract][Full Text] [Related]
18. Combination of active components of Xiexin decoction ameliorates renal fibrosis through the inhibition of NF-κB and TGF-β1/Smad pathways in db/db diabetic mice.
Wu JS; Shi R; Lu X; Ma YM; Cheng NN
PLoS One; 2015; 10(3):e0122661. PubMed ID: 25803610
[TBL] [Abstract][Full Text] [Related]
19. Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.
Carino A; Biagioli M; Marchianò S; Scarpelli P; Zampella A; Limongelli V; Fiorucci S
Pharmacol Res; 2018 May; 131():17-31. PubMed ID: 29530598
[TBL] [Abstract][Full Text] [Related]
20. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
